These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 24323360)
1. Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro. Bryan JN; Kumar SR; Jia F; Balkin ER; Lewis MR Cell Biol Int; 2014 Feb; 38(2):187-97. PubMed ID: 24323360 [TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer. Chen M; Shabashvili D; Nawab A; Yang SX; Dyer LM; Brown KD; Hollingshead M; Hunter KW; Kaye FJ; Hochwald SN; Marquez VE; Steeg P; Zajac-Kaye M Mol Cancer Ther; 2012 Feb; 11(2):370-82. PubMed ID: 22203734 [TBL] [Abstract][Full Text] [Related]
3. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI. Ye K; Wang S; Wang J; Han H; Ma B; Yang Y Cancer Sci; 2016 Dec; 107(12):1851-1857. PubMed ID: 27685841 [TBL] [Abstract][Full Text] [Related]
4. Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells. Zhou P; Lu Y; Sun XH Mol Vis; 2012; 18():22-8. PubMed ID: 22259221 [TBL] [Abstract][Full Text] [Related]
5. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Billam M; Sobolewski MD; Davidson NE Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643 [TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis. Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells. Savickiene J; Treigyte G; Jonusiene V; Bruzaite R; Borutinskaite VV; Navakauskiene R Mol Cell Biochem; 2012 Jan; 359(1-2):245-61. PubMed ID: 21842375 [TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509 [TBL] [Abstract][Full Text] [Related]
10. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Tan W; Zhou W; Yu HG; Luo HS; Shen L Biochem Biophys Res Commun; 2013 Jan; 430(1):250-5. PubMed ID: 23167995 [TBL] [Abstract][Full Text] [Related]
11. Zebularine exerts its antiproliferative activity through S phase delay and cell death in human malignant mesothelioma cells. Takemura Y; Satoh M; Hatanaka K; Kubota S Biosci Biotechnol Biochem; 2018 Jul; 82(7):1159-1164. PubMed ID: 29685095 [TBL] [Abstract][Full Text] [Related]
12. Effect of Zebularine in Comparison to and in Combination with Trichostatin A on CIP/KIP Family (p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2), DNMTs (DNMT1, DNMT3a, and DNMT3b), Class I HDACs (HDACs 1, 2, 3) and Class II HDACs (HDACs 4, 5, 6) Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer LS 174T Cell Line. Sanaei M; Kavoosi F Asian Pac J Cancer Prev; 2020 Jul; 21(7):2131-2139. PubMed ID: 32711442 [TBL] [Abstract][Full Text] [Related]
13. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Kim HJ; Kim JH; Chie EK; Young PD; Kim IA; Kim IH Radiat Oncol; 2012 Mar; 7():39. PubMed ID: 22429326 [TBL] [Abstract][Full Text] [Related]
14. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine. Champion C; Guianvarc'h D; Sénamaud-Beaufort C; Jurkowska RZ; Jeltsch A; Ponger L; Arimondo PB; Guieysse-Peugeot AL PLoS One; 2010 Aug; 5(8):e12388. PubMed ID: 20808780 [TBL] [Abstract][Full Text] [Related]
16. DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site. van Bemmel DM; Brank AS; Eritja R; Marquez VE; Christman JK Biochem Pharmacol; 2009 Sep; 78(6):633-41. PubMed ID: 19467223 [TBL] [Abstract][Full Text] [Related]
17. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells. Cheng JC; Weisenberger DJ; Gonzales FA; Liang G; Xu GL; Hu YG; Marquez VE; Jones PA Mol Cell Biol; 2004 Feb; 24(3):1270-8. PubMed ID: 14729971 [TBL] [Abstract][Full Text] [Related]
18. The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells. Ruiz-Magaña MJ; Rodríguez-Vargas JM; Morales JC; Saldivia MA; Schulze-Osthoff K; Ruiz-Ruiz C Int J Cancer; 2012 Mar; 130(5):1195-207. PubMed ID: 21455989 [TBL] [Abstract][Full Text] [Related]
19. Investigation of the Effect of Zebularine in Comparison to and in Combination with Trichostatin A on p21Cip1/Waf1/ Sdi1, p27Kip1, p57Kip2, DNA Methyltransferases and Histone Deacetylases in Colon Cancer LS 180 Cell Line. Sanaei M; Kavoosi F Asian Pac J Cancer Prev; 2020 Jun; 21(6):1819-1828. PubMed ID: 32592383 [TBL] [Abstract][Full Text] [Related]
20. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer. Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]